INVO Fertility enters $15M equity purchase agreement with Alumni Capital; authorized shares increased to 250M

INVO Fertility, Inc.

Entered Any Market Purchase Agreement with Alumni Capital LP for up to $15M (can be increased to $50M) to sell common stock at discounts.
Stockholders approved increase in authorized common shares from 50M to 250M on July 23, 2026.
Company may sell shares at VWAP-based prices (94%, 97%, or 85% of market) at its option; proceeds for clinic acquisitions and general corporate.
Commitment fee of 1% of commitment amount payable in cash or shares; term through June 30, 2028 or earlier.
Stockholders also approved issuance of up to 1,893,492 shares upon warrant exercise and amendment to 2019 Stock Incentive Plan to 1M shares.

item 1.01 item 3.02 item 5.03 item 5.07 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.